Picture of Dynavax Technologies logo

DVAX — Dynavax Technologies News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

Dynavax Technologies Corp reports results for the quarter ended in March - Earnings Summary

* Dynavax Technologies Corp  DVAX.OQ  reported a quarterly
adjusted loss of 19 cents​​ per share for the quarter ended in
March. The mean expectation of five analysts for the quarter was
for a loss of 13 cents per share.
    * Revenue fell 58.8% to $46.93 million from a year ago;
analysts
expected $38.59 million. 
    * Dynavax Technologies Corp's reported EPS for the quarter
was a
loss of 19 cents​.
    * The mean earnings estimate of analysts had risen by
about 32.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Dynavax Technologies Corp shares had risen by 7.2% this
quarter and lost 1.1% so far this year.
    * The company reported a quarterly loss of $24.33 million.
    * Wall Street's median 12-month price target for Dynavax
Technologies Corp is $25.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
2 at 10:06 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.13          -0.19          Missed
 Dec. 31 2022      0.43           0.45           Beat
 Sep. 30 2022      0.33           0.43           Beat
 Jun. 30 2022      0.22           0.87           Beat

Recent news on Dynavax Technologies

See all news